Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins
Mark S. Moehle, João Paulo Lima Daher, Travis D. Hull, et al.
Human Molecular Genetics (2015) Vol. 24, Iss. 15, pp. 4250-4267
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis
Chi G. Weindel, E. Martínez, Xiao Zhao, et al.
Cell (2022) Vol. 185, Iss. 17, pp. 3214-3231.e23
Open Access | Times Cited: 233
Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration
João Paulo Lima Daher, Hisham Abdelmotilib, Xianzhen Hu, et al.
Journal of Biological Chemistry (2015) Vol. 290, Iss. 32, pp. 19433-19444
Open Access | Times Cited: 190
LRRK2 modifies α-syn pathology and spread in mouse models and human neurons
Gregor Bieri, Michel Brahic, Luc Bousset, et al.
Acta Neuropathologica (2019) Vol. 137, Iss. 6, pp. 961-980
Open Access | Times Cited: 164
Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo
Е. А. Козина, Shankar Sadasivan, Yun Jiao, et al.
Brain (2018) Vol. 141, Iss. 6, pp. 1753-1769
Open Access | Times Cited: 126
LRRK2 regulation of immune-pathways and inflammatory disease
Rebecca L. Wallings, Malú G. Tansey
Biochemical Society Transactions (2019) Vol. 47, Iss. 6, pp. 1581-1595
Open Access | Times Cited: 125
Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson’s disease
Kwang S. Kim, Paul C. Marcogliese, Jungwoo Yang, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 22
Open Access | Times Cited: 105
LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase
Insup Choi, Beomsue Kim, Ji-Won Byun, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 100
Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation
Jesús Madero‐Pérez, Elena Fdez, Belén Fernández, et al.
Molecular Neurodegeneration (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 100
RAB8, RAB10 and RILPL1 contribute to both LRRK2 kinase–mediated centrosomal cohesion and ciliogenesis deficits
Antonio Jesús Lara Ordóñez, Belén Fernández, Elena Fdez, et al.
Human Molecular Genetics (2019) Vol. 28, Iss. 21, pp. 3552-3568
Open Access | Times Cited: 88
Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent manner
Bojan Shutinoski, Mansoureh Hakimi, Irene E. Harmsen, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 511
Closed Access | Times Cited: 83
LRRK2 and Rab10 coordinate macropinocytosis to mediate immunological responses in phagocytes
Zhiyong Liu, Enquan Xu, Hien Zhao, et al.
The EMBO Journal (2020) Vol. 39, Iss. 20
Open Access | Times Cited: 82
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
Enquan Xu, Ravindra Boddu, Hisham Abdelmotilib, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 48
LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition
Narayana Yadavalli, Shawn M. Ferguson
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 31
Open Access | Times Cited: 32
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 8
LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease
Heyne Lee, William James, Sally A. Cowley
Biochemical Society Transactions (2017) Vol. 45, Iss. 1, pp. 131-139
Open Access | Times Cited: 83
Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers
Shijie Wang, Zhiyong Liu, Tao Ye, et al.
Acta Neuropathologica Communications (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 77
G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice
Salvatore Novello, Ludovico Arcuri, Sandra Doveró, et al.
Neurobiology of Disease (2018) Vol. 120, pp. 21-33
Open Access | Times Cited: 62
Leucine Rich Repeat Kinase 2 and Innate Immunity
Diba Ahmadi Rastegar, Nicolas Dzamko
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 55
Mutant LRRK2 exacerbates immune response and neurodegeneration in a chronic model of experimental colitis
Diego Cabezudo, George Tsafaras, Eva Van Acker, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 2, pp. 245-261
Open Access | Times Cited: 18
Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics
Farah H. Bardai, Dalila G. Ordonez, Rachel M. Bailey, et al.
PLoS Biology (2018) Vol. 16, Iss. 12, pp. e2006265-e2006265
Open Access | Times Cited: 53
LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurotoxicity
Senthilkumar S. Karuppagounder, Yulan Xiong, Yunjong Lee, et al.
Journal of Chemical Neuroanatomy (2016) Vol. 76, pp. 90-97
Open Access | Times Cited: 47
LRRK2 as a target for modulating immune system responses
Isabella Russo, Luigi Bubacco, Elisa Greggio
Neurobiology of Disease (2022) Vol. 169, pp. 105724-105724
Open Access | Times Cited: 24
Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease
Shijie Wang, Shakthi Unnithan, Nicole Bryant, et al.
Movement Disorders (2022) Vol. 37, Iss. 7, pp. 1454-1464
Open Access | Times Cited: 24
α2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth
Sajina GC, Kaysaw Tuy, Lucas Rickenbacker, et al.
JCI Insight (2022) Vol. 7, Iss. 21
Open Access | Times Cited: 24
Targeting LRRK2 in Parkinson’s disease: an update on recent developments
Sharon L. Chan, Eng‐King Tan
Expert Opinion on Therapeutic Targets (2017) Vol. 21, Iss. 6, pp. 601-610
Closed Access | Times Cited: 45
Page 1 - Next Page

Scroll to top